Tolerability of Sifrol® in Ambulatory Patients Suffering From Parkinson's Disease
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to obtain information about the co-operation of the different physician-colleagues in
the treatment of patients with Parkinson's disease, both in private practices and clinics and
about the primary treatment strategies in the pharmacotherapy of Parkinson's disease and to
collect data on the tolerability of Sifrol® in ambulatory patients suffering from Parkinson's
disease under routing conditions